Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Stability Testing of Gel Products – V 2.0

Posted on By

Gel Manufacturing: SOP for Stability Testing of Gel Products – V 2.0

Standard Operating Procedure for Stability Testing of Gel Products


Department Gel Manufacturing
SOP No. SOP/GM/066/2025
Supersedes SOP/GM/066/2022
Page No. Page 1 of 13
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2026

1. Purpose

To define a standardized procedure for conducting stability testing of gel products under various environmental conditions to ensure product quality, efficacy, and safety throughout its shelf life.

2. Scope

This procedure applies to all finished gel products manufactured at the facility and subjected to real-time

and accelerated stability testing.

3. Responsibilities

  • QC Analyst: To perform sampling, testing, and documentation.
  • QA Executive: To review stability data and trend reports.
  • QC Head: To approve final reports and recommend shelf life.

4. Accountability

Head – Quality Control shall be accountable for ensuring proper execution and compliance with this SOP.

See also  Gel Manufacturing: SOP for Developing Herbal Gels - V 2.0

5. Procedure

5.1 Sample Selection

  1. Collect samples from three initial commercial batches or exhibit batches as per protocol.
  2. Ensure representative packaging (e.g., tubes, jars) for each market presentation.

5.2 Storage Conditions

Place samples in validated stability chambers at specified ICH conditions:

  • Long-Term: 25°C ± 2°C / 60% RH ± 5% RH
  • Accelerated: 40°C ± 2°C / 75% RH ± 5% RH
  • Intermediate (if required): 30°C ± 2°C / 65% RH ± 5% RH

5.3 Time Points

Perform testing at the following intervals unless otherwise specified:

  • Long-Term: 0, 3, 6, 9, 12, 18, and 24 months
  • Accelerated: 0, 3, and 6 months

5.4 Stability Testing Parameters

  • Appearance (color, clarity, homogeneity)
  • Odor and pH
  • Viscosity and Spreadability
  • Assay of Active Ingredient(s)
  • Preservative Content (if applicable)
  • Microbial Limit Test
  • Preservative Efficacy Test (selected batches)
  • Container-closure integrity (where applicable)

5.5 Testing Procedure

  1. Withdraw required quantity of each sample at respective intervals.
  2. Perform testing as per validated analytical methods and SOPs.
  3. Document all results with proper calculations and chromatograms where applicable.
See also  Gel Manufacturing: SOP for Dispensing Active Pharmaceutical Ingredients (APIs) for Gels - V 2.0

5.6 Data Review and Trending

  1. Compare results with initial values and specifications.
  2. Identify and document any trends or deviations.
  3. Initiate investigation if OOS or atypical trends are observed.

5.7 Report Preparation

  1. Compile a stability report at each milestone and at study completion.
  2. Include results, graphs, conclusions, and any recommendations for shelf life adjustment.

5.8 Document Retention

All raw data, printouts, and reports shall be archived in the QC documentation room for a minimum of five years or as per regulatory requirement.

6. Abbreviations

  • ICH: International Council for Harmonisation
  • RH: Relative Humidity
  • OOS: Out of Specification
  • SOP: Standard Operating Procedure

7. Documents

  1. Stability Protocol Template – Annexure-1
  2. Stability Summary Report Format – Annexure-2
  3. Stability Sample Withdrawal Log – Annexure-3
  4. Stability Data Trending Chart – Annexure-4

8. References

  • ICH Q1A(R2): Stability Testing of New Drug Substances and Products
  • WHO Technical Report Series – Stability Studies
  • Internal Method Validation SOPs
See also  Gel Manufacturing: SOP for Preparation and Usage of Disinfectant Solutions - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Stability Protocol Template

Product Name
Batch No.
Storage Conditions
Time Points
Testing Parameters
Prepared By
Approved By

Annexure-2: Stability Summary Report Format

Time Point Parameter Result Limit Remarks
0 Month pH
3 Months Assay
6 Months Viscosity

Annexure-3: Stability Sample Withdrawal Log

Date Batch No. Storage Condition Time Point Withdrawn By Signature

Annexure-4: Stability Data Trending Chart

Parameter Time Point Observed Value Trend Observed Remarks
Assay 0M, 3M, 6M, 12M

Revision History

Revision Date Revision No. Details Reason Approved By
08/05/2022 1.0 Initial Issue New SOP QA Head
02/06/2025 2.0 Revised per ICH update Compliance Requirement QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: API Manufacturing: SOP for Complaint Handling and Investigation – V 2.0
Next Post: Analytical Method Development: Peak Identification by m/z Ratios – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version